why choose us

First received: April 25, 2023

Clinical Trial: STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Fibrostenotic Crohn's Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 2a, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

Brief Summary: The goal of this clinical trial is to learn about the safety, pharmacokinetics and pharmacodynamics of AGMB-129 in patients with Crohn's disease.The main questions it aims to answer are:is AGMB-129 safe and well tolerated in these patients?what does the body do to the drug (pharmacokinetics)?what does the drug do to the body (pharmacodynamics)?The participants will be in the study for a total duration of up to 19 weeks, including a 5-week screening period, a 12-week double-blind, placebo-controlled treatment…

Read more